Cash Dividend On The Way From Guggenheim Strategic Opportunities Fund (GOF)

Looking at the universe of stocks we cover at Dividend Channel, on 6/11/14, Guggenheim Strategic Opportunities Fund (GOF) will trade ex-dividend, for its monthly dividend of $0.1821, payable on 6/30/14. As a percentage of GOF's recent stock price of $21.84, this dividend works out to approximately 0.83%, so look for shares of Guggenheim Strategic Opportunities Fund to trade 0.83% lower — all else being equal — when GOF shares open for trading on 6/11/14.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for GOF, showing historical dividends prior to the most recent $0.1821 declared by Guggenheim Strategic Opportunities Fund:

GOF+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from GOF is likely to continue, and whether the current estimated yield of 10.01% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of GOF shares, versus its 200 day moving average:

Guggenheim Strategic Opportunities Fund 200 Day Moving Average Chart

Looking at the chart above, GOF's low point in its 52 week range is $20.41 per share, with $22.79 as the 52 week high point — that compares with a last trade of $21.81.

In Monday trading, Guggenheim Strategic Opportunities Fund shares are currently up about 0.5% on the day.

More from Stocks

Tesla CEO Elon Musk Is a Rock Star: Kiss Icon Gene Simmons

Tesla CEO Elon Musk Is a Rock Star: Kiss Icon Gene Simmons

The Best Investment Advice? Stay Diversified

The Best Investment Advice? Stay Diversified

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Listen: Should You Buy Cisco Now?

Listen: Should You Buy Cisco Now?

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business